Accès libre

Assessment of hyperbaric oxygenation treatment response in parotid glands by T2 mapping following radiotherapy for head and neck tumours

Jernej Vidmar
Jernej Vidmar
, 
Ksenija Cankar
Ksenija Cankar
, 
Maja Groselj
Maja Groselj
, 
Zarko Finderle
Zarko Finderle
 et 
Igor Sersa
Igor Sersa
   | 11 févr. 2022
Radiology and Oncology's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Article Category: Research Article
Publié en ligne: 11 févr. 2022
Pages: 60 - 68
Reçu: 23 sept. 2021
Accepté: 10 déc. 2021
DOI: https://doi.org/10.2478/raon-2022-0001
© 2022 Jernej Vidmar, Ksenija Cankar, Maja Groselj, Zarko Finderle, Igor Sersa, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1

Representative T2 maps of parotid glands in a single transversal slice in a patient following radiotherapy for head and neck tumour before (A) and after hyperbaric oxygenation therapy (HBOT) (B) and in healthy control (C). Region of interest (ROI) on the ipsilateral side is encircled by green and on the contralateral side by the white-blue colour. Retromandibular veins (white arrows in B) were always carefully omitted from the ROI.
Representative T2 maps of parotid glands in a single transversal slice in a patient following radiotherapy for head and neck tumour before (A) and after hyperbaric oxygenation therapy (HBOT) (B) and in healthy control (C). Region of interest (ROI) on the ipsilateral side is encircled by green and on the contralateral side by the white-blue colour. Retromandibular veins (white arrows in B) were always carefully omitted from the ROI.

Figure 2

A correlation between an irradiation dose and variability of T2 values in contralateral parotid glands before hyperbaric oxygenation therapy (HBOT).
A correlation between an irradiation dose and variability of T2 values in contralateral parotid glands before hyperbaric oxygenation therapy (HBOT).

Figure 3

A correlation between the mean T2 values in ipsilateral parotid glands and stimulated salivary flow before hyperbaric oxygenation therapy (HBOT) (A) and unstimulated salivary flow after HBOT (B).
A correlation between the mean T2 values in ipsilateral parotid glands and stimulated salivary flow before hyperbaric oxygenation therapy (HBOT) (A) and unstimulated salivary flow after HBOT (B).

Figure 4

A correlation between the mean T2 values in contralateral parotid glands and unstimulated (A) and stimulated salivary flow (B) after hyperbaric oxygenation therapy (HBOT).
A correlation between the mean T2 values in contralateral parotid glands and unstimulated (A) and stimulated salivary flow (B) after hyperbaric oxygenation therapy (HBOT).

Mean T2 and T2 variability values of parotid glands in patients following radiotherapy for head and neck tumours before and after hyperbaric oxygenation therapy (HBOT) and in healthy controls

Ipsilateral side (N = 18) Contralateral side (N = 18) Controls (N = 18)
before HBOT after HBOT before HBOT after HBOT
MEAN T2 (ms) 121 ± 20† 113 ± 16†* 107 ± 21** 103 ± 14 96 ± 12
T2 VARIABILITY (ms) 30 ± 8 25 ± 8* 21 ± 8 19 ± 6 16 ± 4

Correlations between mean T2 or T2variability and pH of unstimulated saliva before and after hyperbaric oxygenation therapy (HBOT) (R-correlation coefficients and p-values)

Ipsilateral side (N = 18) Contralateral side (N = 18)
before HBOT after HBOT before HBOT after HBOT
R p R p R p R p
Mean T2 (ms) -0.647 0.0037 -0.571 0.0133 -0.557 0.0164 -0.675 0.0021
T2 variability (ms) -0.595 0.0092 -0.506 0.0323 -0.130 0.607 -0.588 0.0133

Salivary flow, pH, and buffer capacity in patients following radiotherapy for head and neck tumours before and after hyperbaric oxygenation therapy (HBOT) and in healthy controls

before HBOT (N = 18) after HBOT (N = 18) Controls (N = 18)
Unstimulated (median and salivary IQR) flow (mL/min) 0.22 (0.04-0.54) † 0.32 (0.08-0.70)*† 0.61 (0.49-0.99)
pH (mean of unstimulated ± SD) saliva 6.61± 0.69† 6.72 ± 0.71† 7.56 ± 0.53
Stimulated (mean ± SD) salivary flow (mL/min) 0.82 ± 0.60† 0.90 ± 0.64† 2.04 ± 0.91
pH (mean of stimulated ± SD) saliva 7.38 ± 0.74† 7.48 ± 0.51† 8.00 ± 0.28
Buffering (median capacity and IQR) of stimulated saliva 2.00 (1.75-3.00) 3.00 (2.00-3.00)* 3.00 (2.00-3.00)
eISSN:
1581-3207
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology
RSS Feed de la revue